PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Introduces RESOURCES™ Protegrity™ GI for Canines - Kemin is pleased to offer RESOURCES™ Protegrity™ GI, a clinical-strength health supplement developed to promote a balanced GI system for the overall health and well-being of dogs
Kemin Introduces RESOURCES™ Protegrity™ GI for Canines

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2012/10/16 - Kemin is pleased to offer RESOURCES™ Protegrity™ GI, a clinical-strength health supplement developed to promote a balanced GI system for the overall health and well-being of dogs.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

GI issues are a frequent reason why people bring their dogs to a veterinarian. Whether dogs are challenged with digestive problems from stress, boarding, antibiotics, dietary indiscretions or other circumstances, Protegrity GI can be taken to help improve stool quality and help support normal GI health.

Protegrity GI is the only probiotic supplement in the companion animal marketplace that contains the patented probiotic Bacillus subtilis PB6, which is backed by over a decade of research and has been scientifically proven to be safe, stable and beneficial. Isolated from a natural source by Kemin scientists and characterized as a non-GMO strain, PB6 promotes optimum GI health by inhibiting the growth of several key intestinal pathogens, including those associated with diarrhea, to help maintain normal stool quality and GI function. In addition, PB6 does not interfere with the good bacteria that are necessary for optimal GI health. Along with PB6, Protegrity GI contains a proprietary blend of other probiotics and prebiotics to provide complete protection and to help maintain GI health.

When choosing a probiotic, it’s important to remember that not all probiotics have the same activity in the lab or in an animal. While other products in the marketplace may contain Bacillus subtilis species, only Protegrity GI contains the patented and proven PB6 strain. Research has shown that PB6 works better than other Bacillus subtilis strains to help maintain optimal GI balance and to help provide better protection against intestinal pathogens. Protegrity GI also provides a high level of stability, meaning that it maintains its beneficial effects throughout its shelf life.
While many probiotics on the market are taken in powder or tablet form, which are often unfavorable and inconvenient, Protegrity GI is available in a highly palatable chew. Protegrity GI offers dogs an easy-to-consume probiotic—making maintaining gut health easier for dogs, dog owners and veterinarians alike.

Protegrity GI is part of the RESOURCES brand, a complete line of health supplements for dogs and cats. The product line includes supplements for immune and urinary support as well as joint and general wellness. RESOURCES products are available for purchase exclusively through licensed, practicing veterinarians. More information on Protegrity GI can be obtained by calling Kemin at 877-738-7454 or by visiting Kemin.com/Resources.

About Kemin – Inspired Molecular Solutions™
Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has more than 1,600 employees and operates in 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

RESOURCES and Protegrity are trademarks of Kemin Industries, Inc.
Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Introduces RESOURCES™ Protegrity™ GI for Canines

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Kemin Industries, Inc. |
Publisher Contact: Erin Hockman / Tin Marien - Kemin.com 
515-559-5349 / +32 14 28 62 60 erin.hockman[.]kemin.com / tin.marien[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)